JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank36
3Y CAGR-28.5%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-28.5%/yr
vs -29.2%/yr prior
Acceleration
+0.6pp
Accelerating
Percentile
P36
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20252.44%
20243.26%
20236.81%
20226.68%
20213.16%
2020-6.22%
201924.13%
201826.54%
20179.58%
20163.45%